原发性纵隔大B细胞淋巴瘤治疗效果回顾性评价

LLM Dergi Pub Date : 2018-07-16 DOI:10.5578/LLM.66467

Erden Atilla, Pinar Ataca Atilla, G. Seval, S. Toprak, O. Ilhan, Ö. Arslan, G. Gurman, T. Demirer, M. Ozcan

{"title":"原发性纵隔大B细胞淋巴瘤治疗效果回顾性评价","authors":"Erden Atilla, Pinar Ataca Atilla, G. Seval, S. Toprak, O. Ilhan, Ö. Arslan, G. Gurman, T. Demirer, M. Ozcan","doi":"10.5578/LLM.66467","DOIUrl":null,"url":null,"abstract":"Objective: Primary mediastinal large B cell lymphomas (PMLBCL) are aggressive, rare lymphomas known to originate from the thymus medullary B cells. In PMLBCL, which accounts for about 2% of non-Hodgkin’s lymphomas, the referral is usually due to bulky disease. This study summarizes the characteristics, prognosis and survivals of PMLBCL patients with diagnosed and treated in our clinic. Erden AtİllA1,2, Pınar AtAcA AtİllA1,2, Güldane cEnGİz SEvAl1, Selami Koçak toPrAK1, osman İlhAn1, Önder ArSlAn1, Günhan GürmAn1, taner DEmİrEr1, muhit ÖzcAn1 1 Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara, Türkiye 2 Baylor College of Medicine, Center for Gene and Cell Therapy, Houston, TX, ABD Uzm. Dr. Erden AtİllA Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara-Türkiye Geliş: 10.09.2018 Kabul: 26.09.2018 E-posta: erdenatilla@gmail.com Yazışma Adresi ARAŞTIRMA LLM Dergi 2018;2(3):60-64 • 10.5578/llm.66467","PeriodicalId":354438,"journal":{"name":"LLM Dergi","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Retrospective Evaluation of Primary Mediastinal Large B Cell Lymphoma Treatment Results\",\"authors\":\"Erden Atilla, Pinar Ataca Atilla, G. Seval, S. Toprak, O. Ilhan, Ö. Arslan, G. Gurman, T. Demirer, M. Ozcan\",\"doi\":\"10.5578/LLM.66467\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Primary mediastinal large B cell lymphomas (PMLBCL) are aggressive, rare lymphomas known to originate from the thymus medullary B cells. In PMLBCL, which accounts for about 2% of non-Hodgkin’s lymphomas, the referral is usually due to bulky disease. This study summarizes the characteristics, prognosis and survivals of PMLBCL patients with diagnosed and treated in our clinic. Erden AtİllA1,2, Pınar AtAcA AtİllA1,2, Güldane cEnGİz SEvAl1, Selami Koçak toPrAK1, osman İlhAn1, Önder ArSlAn1, Günhan GürmAn1, taner DEmİrEr1, muhit ÖzcAn1 1 Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara, Türkiye 2 Baylor College of Medicine, Center for Gene and Cell Therapy, Houston, TX, ABD Uzm. Dr. Erden AtİllA Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara-Türkiye Geliş: 10.09.2018 Kabul: 26.09.2018 E-posta: erdenatilla@gmail.com Yazışma Adresi ARAŞTIRMA LLM Dergi 2018;2(3):60-64 • 10.5578/llm.66467\",\"PeriodicalId\":354438,\"journal\":{\"name\":\"LLM Dergi\",\"volume\":\"22 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"LLM Dergi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5578/LLM.66467\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"LLM Dergi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5578/LLM.66467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

目的：原发性纵隔大 B 细胞淋巴瘤（PMLBCL原发性纵隔大B细胞淋巴瘤（PMLBCL）是一种侵袭性的罕见淋巴瘤，已知起源于胸腺髓质B细胞。PMLBCL约占非霍奇金淋巴瘤的2%，通常因病变巨大而转诊。本研究总结了在我院接受诊断和治疗的PMLBCL患者的特征、预后和存活率。Erden AtİllA1,2, Pınar AtAcA AtİllA1,2, Güldane cEnGİz SEvAl1, Selami Koçak toPrAK1, osman İlhAn1, Önder ArSlAn1, Günhan GürmAn1, taner DEmİrEr1、muhit ÖzcAn1 1 Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara, Türkiye 2 Baylor College of Medicine, Center for Gene and Cell Therapy, Houston, TX, ABD Uzm.Dr. Erden AtİllA Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara-Türkiye Geliş：10.09.2018 Kabul: 26.09.2018 E-posta: erdenatilla@gmail.com Yazışma Adresi ARAŞTIRMA LLM Dergi 2018;2(3):60-64 - 10.5578/llm.66467

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Retrospective Evaluation of Primary Mediastinal Large B Cell Lymphoma Treatment Results

Objective: Primary mediastinal large B cell lymphomas (PMLBCL) are aggressive, rare lymphomas known to originate from the thymus medullary B cells. In PMLBCL, which accounts for about 2% of non-Hodgkin’s lymphomas, the referral is usually due to bulky disease. This study summarizes the characteristics, prognosis and survivals of PMLBCL patients with diagnosed and treated in our clinic. Erden AtİllA1,2, Pınar AtAcA AtİllA1,2, Güldane cEnGİz SEvAl1, Selami Koçak toPrAK1, osman İlhAn1, Önder ArSlAn1, Günhan GürmAn1, taner DEmİrEr1, muhit ÖzcAn1 1 Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara, Türkiye 2 Baylor College of Medicine, Center for Gene and Cell Therapy, Houston, TX, ABD Uzm. Dr. Erden AtİllA Ankara Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Ankara-Türkiye Geliş: 10.09.2018 Kabul: 26.09.2018 E-posta: erdenatilla@gmail.com Yazışma Adresi ARAŞTIRMA LLM Dergi 2018;2(3):60-64 • 10.5578/llm.66467

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

LLM Dergi

自引率

0.00%

发文量